Ochre Bio Strengthens Leadership Team and Board of Directors with Liver Disease Translational Expertise April 5, 2023
Ochre Bio Announces Formation of Scientific Strategy Board with Liver Disease Experts October 20, 2022
Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases October 10, 2022